Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cudis (CUDIS) vs Immunefi (IMU) Price & Performance

Price performance (Past 24H)

Key statistics

Cudis vs Immunefi — how do they compare? Cudis trades at Rp18.94 (market cap Rp4,65M, Rp7,33M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Immunefi is far larger — about 5.8× Cudis's market cap, and Cudis's circulating supply is 247,5M / 1B CUDIS (25%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Cudis for 11 Days and Immunefi for 5 Days on average.

CUDISIMU
Market Cap
Rp4,65MRp27,03M
Volume (24h)
Rp7,33MRp39,91M
Circulating Supply
247,5M / 1B CUDIS (25%)873,4M / 10B IMU (9%)
Typical Hold Time
11 Days5 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cudis

Cudis is trading at Rp19.346 with a market cap of Rp4.78M, showing bearish technical signals with 13 sell signals in moving averages. The token has limited circulation at 25% of max supply and short average hold time of 11 days. Current price sits near key support levels with RSI indicators suggesting potential oversold conditions. No recent protocol updates or ecosystem developments were identified.

Overall outlook remains cautious due to strong bearish technical signals and limited market depth. Key opportunity lies in potential oversold bounce from support levels, while major risks include low liquidity, high volatility, and the token's early adoption stage. Investors should monitor for increased trading volume and network activity.

Immunefi

IMU token shows limited market activity with a modest market cap of Rp27.03M and only 9% circulating supply. The token exhibits low trading volume and minimal network activity, with a short average hold time of 5 days indicating speculative trading patterns. Recent coverage appears to confuse this cryptocurrency with a corporate entity, creating market confusion.

Outlook remains cautious due to extremely low liquidity and market confusion with traditional equity. Key risk is entity misidentification impacting proper valuation. Opportunity exists if protocol utility develops, but current fundamentals are weak with minimal ecosystem activity.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CUDIS
99% Buy1% Sell
Avg holding period · 11 Days
IMU

No sentiment data available yet.

About Cudis

CUDIS is creating the first-ever Longevity Protocol aimed at making longevity trackable, personalized, and rewarding. By integrating the CUDIS Ring, an AI-powered Longevity Hub, and a blockchain-driven Super App, users will have complete ownership of their health data, receive real-time insights on their longevity, and gain economic incentives for optimizing their biological health. CUDIS is building a new ecosystem for longevity that includes realistic and effective products, programs, and services, in collaboration with partners around the world.

Read more on CUDIS

About Immunefi

Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.

Read more on IMU